Isradipine results

[ParlePark]

aan.com/PressRoom/Home/Pres...

Disappointing...

[KemptonD]

But good too know.

[WinnieThePoo]

Disappointing result. I am surprised because the trial completed.

It refocuses the attention on alpha synuclein for the moment

[ParlePark in reply to WinnieThePoo]

I agree and was cautiously optimistic.

[FMundo]

OK, Inosine bit the dust, now Isradipine. That leaves Nilotinib and a couple of other drugs in the "repurposed drug" category. Let's stay optimistic. (I;m in the Nilotinib Trial).